Literature DB >> 11788068

Risk factors for syphilis among incarcerated women in Rhode Island.

J D Rich1, J C Hou, A Charuvastra, C W Towe, M Lally, A Spaulding, U Bandy, E F Donnelly, A Rompalo.   

Abstract

Syphilis remains a significant problem in the United States. The prison environment is an ideal location to identify and treat syphilis. We undertook this study to describe the correlates and risk factors for syphilis among incarcerated women in Rhode Island. The study design was a review of all cases of syphilis identified through routine screening in the state prison and a case control study. Between 1992 and 1998, among 6,249 incarcerated women, 86 were found to have syphilis; of these, 29 were primary and secondary cases representing 49% of infectious cases of syphilis in women in the state. The prison environment offers a unique opportunity for the diagnosis and treatment of syphilis.

Entities:  

Mesh:

Year:  2001        PMID: 11788068     DOI: 10.1089/108729101753287676

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  3 in total

1.  Sexually transmitted infections among incarcerated women: findings from a decade of screening in a Los Angeles County Jail, 2002-2012.

Authors:  Marjan Javanbakht; Melina Boudov; Laura J Anderson; Mark Malek; Lisa V Smith; Michael Chien; Sarah Guerry
Journal:  Am J Public Health       Date:  2014-09-11       Impact factor: 9.308

2.  Using arrest charge to screen for undiagnosed HIV infection among new arrestees: a study in Los Angeles County.

Authors:  Nina T Harawa; Trista A Bingham; Qiana R Butler; Karen S Dalton; William E Cunningham; Stephanie Behel; Duncan A MacKellar
Journal:  J Correct Health Care       Date:  2009-04

3.  Prevalence and Risk Factors of HIV, Syphilis, Hepatitis B and C Among Female Prisoners in Isfahan, Iran.

Authors:  Zary Nokhodian; Mohammad Reza Yazdani; Majid Yaran; Parisa Shoaei; Mina Mirian; Behrooz Ataei; Anahita Babak; Mehdi Ataie
Journal:  Hepat Mon       Date:  2012-07-30       Impact factor: 0.660

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.